Biotech

All Articles

Lilly- backed weight loss biotech reports IPO

.After elevating $170 million back in February, metabolic disease-focused BioAge Labs has filed to d...

Aelis' marijuana make use of medicine fails phase 2b, driving Indivior to rethink $100M possibility

.Aelis Farma's hopes of getting a quick, favorable decision on a $one hundred thousand choice settle...

ProKidney stops period 3 trial certainly not required for tissue therapy authorization

.ProKidney has actually stopped one of a set of period 3 trials for its own cell treatment for renal...

Vaxcyte rises on 'magnificent' 31-valent PCV gain versus Pfizer

.Vaxcyte revealed what professionals referred to as "magnificent" phase 1/2 data for its 31-valent p...

Recursion's human brain illness trial reveals scant proof of efficiency

.Recursion has discovered via an early exam of its tech-enabled technique to drug exploration, repor...

Acepodia, Pfizer click with each other for chemistry-based cell treatment

.Call it a case of good chemistry: Acepodia, a biotech based on Nobel Prize-winning scientific resea...

Praxis epilepsy drug minimizes seizures in phase 2 trial

.Practice Accuracy Medicines has racked up an additional midphase succeed in epilepsy this year, wit...

Three directors resign as Dyne blog posts blended data for DMD applicant

.After getting away a professional grip numerous years back, Dyne Therapy has shown brand new stage ...

Arrowhead fires off period 3 records in uncommon metabolic ailment before market encounter Ionis

.Arrowhead Pharmaceuticals has revealed its hand in advance of a potential showdown along with Ionis...

Pfizer, Valneva reveal lyme health condition try effective for second enhancer

.Pfizer and also Valneva may possess about 2 additional years to hang around before they create the ...